Literature DB >> 9138520

[Interventional techniques in breast diagnosis: ultrasound controlled puncture biopsy].

R Schulz-Wendtland1, S Krämer, K Döinghaus, M Mitze, N Lang.   

Abstract

From May 1, 1992 to April 30, 1993, we performed 307 ultrasonic guided, high-speed core cut biopsies. In 119 of the 307 women, we dispensed with further surgical and histological procedures when the tentative diagnosis from complementary mammary diagnostic procedures revealed no pathological findings and concurred with the histological results of the core cut biopsy. In 188 women, the biopsy was followed by surgical intervention and correlation of the histological findings. This group of patients showed a sensitivity of 98%, a specificity and positive predictive value of 100%, and a negative predictive value of 91%. If we combine the results of the complementary mammary diagnostics (including the core cut biopsy), then the sensitivity, specificity, and positive and negative predictive values for this surgically and histologically confirmed group of patients reach 100%. In trained hands, the ultra-sonic-guided, high-speed core cut biopsy is a reliable means for determining the histological nature of lesions detected in ultrasonic scans. This technique has been perfected in our facility. Along with preoperative carcinoma detection, it permits us to avoid unnecessary operations when, under defined conditions, there are no pathological findings.

Entities:  

Mesh:

Year:  1997        PMID: 9138520

Source DB:  PubMed          Journal:  Aktuelle Radiol        ISSN: 0939-267X


  2 in total

Review 1.  [Interventional techniques for the breast].

Authors:  M Hahn; H Preibsch
Journal:  Radiologe       Date:  2021-01-11       Impact factor: 0.635

2.  Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up.

Authors:  R Schulz-Wendtland; P A Fasching; M R Bani; M P Lux; S Jud; C Rauh; C Bayer; D L Wachter; A Hartmann; M W Beckmann; M Uder; C R Loehberg
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.